search
Back to results

Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection (A-DONUT)

Primary Purpose

Infectious Disease

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Start Antibiotics / Continue Antibiotics for treatment of bacteriuria
No Antibiotics for treatment of bacteriuria
Sponsored by
Mount Sinai Hospital, Canada
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Infectious Disease focused on measuring Delirium, Antibiotics, Older adults, Urinary Tract Infection

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria Age ≥ 60 and admitted to a hospital ward (including rehabilitation hospital); Active delirium (defined by CAM: [1] inattention AND [2] acute and fluctuating level of consciousness, and either [3] disorganized thinking OR [4] altered mental status; or defined by the 4AT score [www.the4at.com/]) OR physician's diagnosis Less than 24 hours of antibiotics (prior to trial assessment) Either pyuria (defined as white blood cells detected on urinalysis or dipstick) or bacteriuria (defined as bacteria growing on urine culture) Exclusion criteria Fever (temperature > 37.9C or > 100.2F) in the past 48 hours; Signs of lower urinary tract infection symptoms (such as new dysuria) or upper urinary symptoms (such as costovertebral tenderness) In the opinion of the treating physician, there is a reason apart from delirium and urine test results to treat with antibiotics (e.g., pneumonia) Indwelling urinary catheter for > 72 hours

Sites / Locations

  • Sault Area HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

Antibiotics

No Antibiotics

Arm Description

Participants will be randomized to start or continue with antibiotics. Antibiotic type and duration targeted to lower urinary tract infection as directed by the Most Responsible Physician (MRP).

Participants will be randomized to no antibiotics

Outcomes

Primary Outcome Measures

Delirium at day 7 or at day of hospital discharge, whichever is earliest
Delirium will be assessed using Confusion Assessment Method (CAM) or 4 A's Test (4AT). CAM assesses 4 delirium features: [1] inattention, [2] acute and fluctuating level of consciousness, [3] disorganized thinking and [4] altered mental status. For a diagnosis of delirium by CAM, the patient must display feature [1] AND [2], AND EITHER [3] or [4]. The 4AT is scored from 0-12. A score of 4 or more suggests delirium.

Secondary Outcome Measures

Length of hospitalization
Number of participants with bacteremia (bacteria isolated in blood culture)
Number of participants who were transferred to Intensive Care Unit (ICU)
Number of participants who had a fall
Number of participants who were physically restrained
Number of participants who received antipsychotics
Days of antibiotics
Number of participants with C. difficile infection
C. difficile will be defined as a combination of a positive microbiological test for C. difficile (if still hospitalized at the time of diagnosis), or self-reported diagnosis of C. difficile (provided the patient reported diarrhea and receipt of an antibiotic to treat C. difficile)
Number of participants who died
Number of participants who died
Number of participants who were readmitted to hospital
Number of participants who were readmitted to hospital

Full Information

First Posted
July 24, 2023
Last Updated
August 30, 2023
Sponsor
Mount Sinai Hospital, Canada
Collaborators
Sault Area Hospital, Michael Garron Hospital, Unity Health Toronto, The Ottawa Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT06004739
Brief Title
Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection
Acronym
A-DONUT
Official Title
Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 2023 (Anticipated)
Primary Completion Date
September 2027 (Anticipated)
Study Completion Date
September 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Mount Sinai Hospital, Canada
Collaborators
Sault Area Hospital, Michael Garron Hospital, Unity Health Toronto, The Ottawa Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Delirium is an acute confusional state that is experienced by many older adults who are admitted to hospital. To treat delirium the underlying cause needs to be identified promptly, but this is challenging. One of the potential causes of delirium is infection. Urine tests show that most patients experiencing delirium have bacteria in their urine, however, bacteria in the urine is common among older adults, and does not automatically indicate an infection is present. As a result it is difficult to know whether a lower urinary tract infection is present as individuals with delirium are frequently unable to report clinical signs of infection - symptoms of pain or discomfort with urination, having to urinate more frequently or pelvic discomfort. Very often, individuals with delirium are treated with antibiotics despite the fact that it is unknown whether antibiotics help to improve delirium in cases where bacteria in the urine is present. This proposed study is a randomized controlled trial that will examine if adults (age 60 or older) with delirium and suspected infection benefit from taking antibiotics.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infectious Disease
Keywords
Delirium, Antibiotics, Older adults, Urinary Tract Infection

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
550 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Antibiotics
Arm Type
Other
Arm Description
Participants will be randomized to start or continue with antibiotics. Antibiotic type and duration targeted to lower urinary tract infection as directed by the Most Responsible Physician (MRP).
Arm Title
No Antibiotics
Arm Type
Other
Arm Description
Participants will be randomized to no antibiotics
Intervention Type
Drug
Intervention Name(s)
Start Antibiotics / Continue Antibiotics for treatment of bacteriuria
Intervention Description
Participants will be randomized to start or continue with antibiotics (with antibiotic duration determined by the Most Responsible Physician [MRP]). Antibiotics choice to be selected by the MRP.
Intervention Type
Other
Intervention Name(s)
No Antibiotics for treatment of bacteriuria
Intervention Description
Participants will be randomized to no antibiotics
Primary Outcome Measure Information:
Title
Delirium at day 7 or at day of hospital discharge, whichever is earliest
Description
Delirium will be assessed using Confusion Assessment Method (CAM) or 4 A's Test (4AT). CAM assesses 4 delirium features: [1] inattention, [2] acute and fluctuating level of consciousness, [3] disorganized thinking and [4] altered mental status. For a diagnosis of delirium by CAM, the patient must display feature [1] AND [2], AND EITHER [3] or [4]. The 4AT is scored from 0-12. A score of 4 or more suggests delirium.
Time Frame
Delirium will be assessed at the first of day 7 or discharge
Secondary Outcome Measure Information:
Title
Length of hospitalization
Time Frame
Up to 30 days
Title
Number of participants with bacteremia (bacteria isolated in blood culture)
Time Frame
Up to 7 days
Title
Number of participants who were transferred to Intensive Care Unit (ICU)
Time Frame
Up to 7 days
Title
Number of participants who had a fall
Time Frame
Up to 7 days
Title
Number of participants who were physically restrained
Time Frame
Up to 7 days
Title
Number of participants who received antipsychotics
Time Frame
Up to 7 days
Title
Days of antibiotics
Time Frame
Up to 7 days
Title
Number of participants with C. difficile infection
Description
C. difficile will be defined as a combination of a positive microbiological test for C. difficile (if still hospitalized at the time of diagnosis), or self-reported diagnosis of C. difficile (provided the patient reported diarrhea and receipt of an antibiotic to treat C. difficile)
Time Frame
By 30 days
Title
Number of participants who died
Time Frame
By 30 days
Title
Number of participants who died
Time Frame
By 365 days
Title
Number of participants who were readmitted to hospital
Time Frame
By 365 days
Title
Number of participants who were readmitted to hospital
Time Frame
By 30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria Age ≥ 60 and admitted to a hospital ward (including rehabilitation hospital); Active delirium (defined by CAM: [1] inattention AND [2] acute and fluctuating level of consciousness, and either [3] disorganized thinking OR [4] altered mental status; or defined by the 4AT score [www.the4at.com/]) OR physician's diagnosis Less than 24 hours of antibiotics (prior to trial assessment) Either pyuria (defined as white blood cells detected on urinalysis or dipstick) or bacteriuria (defined as bacteria growing on urine culture) Exclusion criteria Fever (temperature > 37.9C or > 100.2F) in the past 48 hours; Signs of lower urinary tract infection symptoms (such as new dysuria) or upper urinary symptoms (such as costovertebral tenderness) In the opinion of the treating physician, there is a reason apart from delirium and urine test results to treat with antibiotics (e.g., pneumonia) Indwelling urinary catheter for > 72 hours
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Michael Fralick, MD
Phone
(416) 586-4800
Email
mike.fralick@mail.utoronto.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael Fralick, MD, PhD
Organizational Affiliation
Sinai Health System
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Chris Kandel, MD, PhD
Organizational Affiliation
Michael Garron Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sault Area Hospital
City
Sault Ste. Marie
State/Province
Ontario
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lucas Castellani

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection

We'll reach out to this number within 24 hrs